Related references
Note: Only part of the references are listed.Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women
Jessica A. Kahn et al.
CLINICAL INFECTIOUS DISEASES (2013)
Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study
Alison G. Abraham et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Clinical Trial Experience With Prophylactic Human Papillomavirus 6/11/16/18 Vaccine in Young Black Women
Liana R. Clark et al.
JOURNAL OF ADOLESCENT HEALTH (2013)
Evaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 months using a pseudovirion neutralization assay
Christine C. Roberts et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
The humoral response to Gardasil® over four years as defined by Total IgG and competitive luminex immunoassay
Darron R. Brown et al.
HUMAN VACCINES (2011)
A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
Stephanie Longet et al.
JOURNAL OF VIROLOGY (2011)
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Anna R. Giuliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Joel M. Palefsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Timothy Wilkin et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women
Nancy A. Hessol et al.
AIDS (2009)
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
Nubia Munoz et al.
LANCET (2009)
Incidence of types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003
Pragna Patel et al.
ANNALS OF INTERNAL MEDICINE (2008)
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study
Gypsyamber D'Souza et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Elmar A. Joura et al.
VACCINE (2008)
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M. Garland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: A hierarchical bayesian meta-analysis
NJ Shire et al.
VACCINE (2006)
Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy
A Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Share Paper
